Proposed symposium- 4 October 2015 Time 0090-0910 0910-0935 0935-1000 1000 1015 1015-1030 1030-1055 1030-1042 1043-1055 1055-1120 1055-1107 1108-1120 1120-1150 1120-1127 1127-1134 1134-1142 1142-1050 1150-1205 12005-1245 1245-1310 1310-1335 1335-1350 1350-1415 1415-1440 1415-1427 1428-1440 1440-1455 1455-1510 1510-1535 1510-1522 1523-1535 1535-1600 1600-1615 1615-1700 Topic Welcome and Introductions Diagnosis & classification of the HDP The impact of pregnancy hypertension - results of community surveillance in Nigeria, Mozambique, Pakistan & India Discussion Coffee Preventing pre-eclampsia Calcium: (i) in whom; (ii) what dose; (iii) when Aspirin: (i) in whom; (ii) what dose; (iii) when Tools for identifying risk in women with pregnancy hypertension Blood pressure Pulse oximetry Risk assessment in women and fetuses when pregnancies are complicated by pregnancy hypertension The women CRADLE miniPIERS & PIERS on the Move fullPIERS The fetuses Discussion Lunch Management of severe pregnancy hypertension Management of non-severe pregnancy hypertension Discussion Magnesium sulphate: standardizing approaches Fluids and gases Fluid management Anaesthesia Discussion Coffee Timing of delivery in women with pregnancy hypertension Chronic hypertension Gestational hypertension and pre-eclampsia Long term outcomes following pregnancy hypertension Discussion Official launch: The FIGO Textbook of the Hypertensive Disorders of Pregnancy Speaker Peter von Dadelszen, UBC Laura Magee, UBC Marianne Vidler, UBC Justus Hofmeyr, UW * José Belizán, ICEHP * Hannah Nathan, KCL * J Mark Ansermino, UBC Andrew Shennan, KCL * Beth Payne, UBC Vivian Ukah, UBC Chantal Mayer, UBC Shuchita Mundle, GMCN * Laura Magee, UBC Jeff Smith, Jhpiego * M Joanne Douglas, UBC o Joanne Douglas, UBC M Jennifer Hutcheon, UBC Ben Mol, UA Tabassum Firoz, UBC Sir Sabaratnam Arulkumaran, FIGO Laura Magee, UBC Peter von Dadelszen, UBC Kevin Dwan, Sabrina’s Foundation David Bloomer, GLOWM *